Search - tctmd.com

Displaying 201 - 220 of 423

Sort: Relevancy | Date

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Industry News

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

October 30, 2016

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Daily News

Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI

Yael L. Maxwell

September 02, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Study Supports Noninferiority of Dedicated Bifurcation Stent: But is That Good Enough for Adoption?

Todd Neale

July 08, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Industry News

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

May 17, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Industry News

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

March 22, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Industry News

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

March 21, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Daily News

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Todd Neale

December 30, 2015

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

Advertisement

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI

The Bioresorbable Stent Story So Far: What Promise? What Price?

Study Supports Noninferiority of Dedicated Bifurcation Stent: But is That Good Enough for Adoption?

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content